Ilumya (Tildrakizumab-Asmn)

Ilumya is used to treat moderate to severe plaque psoriasis. Tildrakizumab-asmn belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural substance in your body (interleukin-23) that may lead to the overgrowth of skin cells and redness/swelling seen in plaque psoriasis. Tildrakizumab-asmn can help lessen the symptoms of plaque psoriasis, including red, scaly, itchy patches of skin.

Indicated for the treatment of:

  • Plaque Psoriasis

Injection Duration:

Frequency of treatment:

  • Loading Dose: Injections at 0, 4
  • Maintenance Dose: Every 12 weeks 

Technology utilized for this injection

  • J-Tip (Eliminates the physical pain of the IV stick)

Why people choose PURE to receive their Ilumya injection:

  • Private Suites
  • Comfortable power recliners
  • Room for guests
  • Desks to work
  • High-speed wi-fi
  • 55” 4K TVs
  • Netflix, iPad, music
  • Snacks and amenities on us
SCHEDULE A CONSULTATION